tiprankstipranks
Trending News
More News >

4basebio PLC Announces Exercise of Options and Share Issuance

Story Highlights
4basebio PLC Announces Exercise of Options and Share Issuance

Don’t Miss TipRanks’ Half-Year Sale

An update from 4basebio UK Societas ( (GB:4BB) ) is now available.

4basebio PLC has announced the exercise of EMI options by two employees, resulting in the issuance of 13,000 new ordinary shares at an exercise price of £1.18 per share, raising £15,340 in total. These shares are set to be admitted to trading on AIM, with the total number of ordinary shares in issue rising to 15,509,393. This development is significant for shareholders as it impacts the total voting rights and may require them to notify changes in their shareholding under the Financial Conduct Authority’s rules.

The most recent analyst rating on (GB:4BB) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on 4basebio UK Societas stock, see the GB:4BB Stock Forecast page.

More about 4basebio UK Societas

4basebio (AIM: 4BB) is an innovation-driven biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and non-viral, cell-targeting nucleic acid delivery platform. The company aims to become a market leader in the manufacture and supply of high-quality synthetic DNA products for research, therapeutic, and pharmacological use, as well as the development of target-specific non-viral vectors for efficient delivery of payloads in patients.

Average Trading Volume: 1,056

Technical Sentiment Signal: Hold

Current Market Cap: £152.4M

For a thorough assessment of 4BB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1